115 related articles for article (PubMed ID: 10235666)
1. Nociception, antinociceptive potency of morphine in streptozotocin induced diabetic rats.
Mahajan AS; Chakrabarty K; Mishra TK; Chakrabarty AS
Indian J Physiol Pharmacol; 1997 Oct; 41(4):416-20. PubMed ID: 10235666
[TBL] [Abstract][Full Text] [Related]
2. Immobilisation stress induced analgesia in diabetic rats.
Mahajan AS; Mishra TK; Chakrabarty K; Chakrabarty AS
Indian J Physiol Pharmacol; 1997 Jul; 41(3):275-9. PubMed ID: 10232773
[TBL] [Abstract][Full Text] [Related]
3. Is the reduced efficacy of morphine in diabetic rats caused by alterations of opiate receptors or of morphine pharmacokinetics?
Courteix C; Bourget P; Caussade F; Bardin M; Coudore F; Fialip J; Eschalier A
J Pharmacol Exp Ther; 1998 Apr; 285(1):63-70. PubMed ID: 9535995
[TBL] [Abstract][Full Text] [Related]
4. Endogenous opioids are involved in morphine and dipyrone analgesic potentiation in the tail flick test in rats.
Hernández-Delgadillo GP; Cruz SL
Eur J Pharmacol; 2006 Sep; 546(1-3):54-9. PubMed ID: 16914138
[TBL] [Abstract][Full Text] [Related]
5. Decreased basal endogenous opioid levels in diabetic rodents: effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception.
Williams J; Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2008 Apr; 584(1):78-86. PubMed ID: 18313663
[TBL] [Abstract][Full Text] [Related]
6. Possible involvement of cholinergic and opioid receptor mechanisms in fluoxetine mediated antinociception response in streptozotocin-induced diabetic mice.
Anjaneyulu M; Chopra K
Eur J Pharmacol; 2006 May; 538(1-3):80-4. PubMed ID: 16650402
[TBL] [Abstract][Full Text] [Related]
7. Narcotics and diabetes. II. Streptozotocin-induced diabetes selectively alters the potency of certain narcotic analgesics. Mechanism of diabetes: morphine interaction.
Simon GS; Borzelleca J; Dewey WL
J Pharmacol Exp Ther; 1981 Aug; 218(2):324-9. PubMed ID: 6114167
[TBL] [Abstract][Full Text] [Related]
8. Felodipine potentiates morphine analgesia in control and streptozotocin diabetic female rats.
Rani MA; Chandran U; Andrade C; Venkataraman BV
Indian J Exp Biol; 1996 Jul; 34(7):663-6. PubMed ID: 8979502
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal co-administration of morphine and nimodipine produces higher antinociceptive effect by synergistic interaction as evident by injecting different doses of each drug in rats.
Gupta H; Verma D; Ahuja RK; Srivastava DN; Wadhwa S; Ray SB
Eur J Pharmacol; 2007 Apr; 561(1-3):46-53. PubMed ID: 17320072
[TBL] [Abstract][Full Text] [Related]
10. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
11. The correlation between antinociceptive activity of narcotics and their antagonists as measured in the mouse tail-flick test and increased synthesis of brain catecholamines.
Bloom AS; Dewey WL; Harris LS; Brosius KK
J Pharmacol Exp Ther; 1976 Jul; 198(1):33-41. PubMed ID: 6793
[TBL] [Abstract][Full Text] [Related]
12. Narcotics and diabetes. I. The effects of streptozotocin-induced diabetes on the antinociceptive potency of morphine.
Simon GS; Dewey WL
J Pharmacol Exp Ther; 1981 Aug; 218(2):318-23. PubMed ID: 7019415
[TBL] [Abstract][Full Text] [Related]
13. Magnesium ions and opioid agonist activity in streptozotocin-induced hyperalgesia.
Bujalska M; Malinowska E; Makulska-Nowak H; Gumułka SW
Pharmacology; 2008; 82(3):180-6. PubMed ID: 18701828
[TBL] [Abstract][Full Text] [Related]
14. Melatonin reduces formalin-induced nociception and tactile allodynia in diabetic rats.
Arreola-Espino R; Urquiza-Marín H; Ambriz-Tututi M; Araiza-Saldaña CI; Caram-Salas NL; Rocha-González HI; Mixcoatl-Zecuatl T; Granados-Soto V
Eur J Pharmacol; 2007 Dec; 577(1-3):203-10. PubMed ID: 17920585
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the antinociceptive effects of oxycodone in diabetic mice.
Nozaki C; Saitoh A; Kamei J
Eur J Pharmacol; 2006 Mar; 535(1-3):145-51. PubMed ID: 16533506
[TBL] [Abstract][Full Text] [Related]
16. Morphine sex-dependently induced place conditioning in adult Wistar rats.
Karami M; Zarrindast MR
Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
[TBL] [Abstract][Full Text] [Related]
17. [A comprehensive study of the neurochemical and immune mechanisms of morphine tolerance: the effects of naloxone].
Litvinova SV; Shul'govskiĭ VV; Gruden' MA; Panchenko LF; Terebilina NN; Aristova VV; Kaliuzhnyĭ AL
Patol Fiziol Eksp Ter; 2000; (1):6-9. PubMed ID: 10741178
[TBL] [Abstract][Full Text] [Related]
18. Roles of different subtypes of opioid receptors in mediating the ventrolateral orbital cortex opioid-induced inhibition of mirror-neuropathic pain in the rat.
Zhao M; Wang JY; Jia H; Tang JS
Neuroscience; 2007 Feb; 144(4):1486-94. PubMed ID: 17184926
[TBL] [Abstract][Full Text] [Related]
19. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
[TBL] [Abstract][Full Text] [Related]
20. Involvement of I2-imidazoline binding sites in positive and negative morphine analgesia modulatory effects.
Gentili F; Cardinaletti C; Carrieri A; Ghelfi F; Mattioli L; Perfumi M; Vesprini C; Pigini M
Eur J Pharmacol; 2006 Dec; 553(1-3):73-81. PubMed ID: 17081513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]